Here are the issue highlights for the JDD August issue with special focus on Psoriasis:
Authors discuss the epidemiological, clinical, and histologic features of melasma and postinflammatory hyperpigmentation and important considerations for both established and emerging treatments in Therapeutic Insights in Melasma and Hyperpigmentation Management (CE credit is available)
Descriptive characteristics were compared in biologic monotherapy and combination therapy groups in Combination Use of Systemic Therapies in Psoriasis: Baseline Characteristics from the Corrona Psoriasis Registry
Authors use data from electronic health records to understand prescribing patterns associated with biologic therapies in Prescribing Patterns Associated With Biologic Therapies for Psoriasis from a United States Medical Records Database
Authors conduct a literature review to evaluate efficacy and safety of topical corticosteroid foams in A Review of Topical Corticosteroid Foams
Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis highlights currently available evidence and demonstrates differences between TNFis and IL-17A inhibitors with regard to efficacy and safety.
Authors determine the safety and effectiveness of HBP-Foam in Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis
Authors examine perceptions of fungal preparations and CLIA certification to identify barriers in Use of In-Office Preparations by Dermatologists for the Diagnosis of Cutaneous Fungal Infections
A post hoc analysis from three phase 3 trials assessed the efficacy and safety of dupilumab vs placebo by racial subgroup in Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials
Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy investigates the maintenance of effect post-treatment.
Authors present a case of a patient with flare of psoriasis plaques in a guttate pattern who responded well to treatment in Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab
Authors present a case of psoriatic lesions precipitated by an upper arm tattoo in Ostraceous Psoriasis Presenting as Koebner Phenomenon in a Tattoo
Did you enjoy this post? Find more JDD Issue Highlights here.
